Cerity Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61.7M | Buy |
788,907
+32,863
| +4% | +$2.65M | 0.07% | 215 |
|
|
2026
Q1 | $65.5M | Sell |
756,044
-34,971
| -4% | -$3.35M | 0.09% | 193 |
|
|
2025
Q4 | $76M | Buy |
791,015
+89,111
| +13% | +$8.66M | 0.11% | 171 |
|
|
2025
Q3 | $66.8M | Buy |
701,904
+92,968
| +15% | +$8.55M | 0.11% | 171 |
|
|
2025
Q2 | $53.1M | Buy |
608,936
+35,902
| +6% | +$3.04M | 0.09% | 188 |
|
|
2025
Q1 | $51.5M | Buy |
573,034
+315,066
| +122% | +$28.2M | 0.1% | 181 |
|
|
2024
Q4 | $22M | Buy |
257,968
+14,660
| +6% | +$1.27M | 0.05% | 299 |
|
|
2024
Q3 | $21.9M | Buy |
243,308
+73,334
| +43% | +$6.17M | 0.05% | 297 |
|
|
2024
Q2 | $13.4M | Sell |
169,974
-54,258
| -24% | -$4.45M | 0.04% | 355 |
|
|
2024
Q1 | $19.5M | Buy |
224,232
+134,151
| +149% | +$11.4M | 0.05% | 299 |
|
|
2023
Q4 | $7.43M | Sell |
90,081
-31,276
| -26% | -$2.38M | 0.02% | 431 |
|
|
2023
Q3 | $9.52M | Buy |
121,357
+27,107
| +29% | +$2.27M | 0.05% | 304 |
|
|
2023
Q2 | $8.31M | Buy |
94,250
+13,454
| +17% | +$1.16M | 0.03% | 380 |
|
|
2023
Q1 | $6.61M | Buy |
80,796
+16,211
| +25% | +$1.32M | 0.02% | 440 |
|
|
2022
Q4 | $5.03M | Sell |
64,585
-33,757
| -34% | -$2.74M | 0.03% | 361 |
|
|
2022
Q3 | $7.95M | Sell |
98,342
-3,705
| -4% | -$333K | 0.1% | 183 |
|
|
2022
Q2 | $9.17M | Buy |
102,047
+13,033
| +15% | +$1.32M | 0.1% | 177 |
|
|
2022
Q1 | $9.55M | Buy |
89,014
+9,742
| +12% | +$1.03M | 0.15% | 127 |
|
|
2021
Q4 | $8.2M | Buy |
79,272
+6,719
| +9% | +$778K | 0.12% | 145 |
|
|
2021
Q3 | $9.09M | Buy |
72,553
+5,522
| +8% | +$715K | 0.2% | 106 |
|
|
2021
Q2 | $8.32M | Buy |
67,031
+2,831
| +4% | +$355K | 0.18% | 109 |
|
|
2021
Q1 | $7.58M | Sell |
64,200
-4,013
| -6% | -$470K | 0.18% | 116 |
|
|
2020
Q4 | $7.99M | Buy |
68,213
+1,279
| +2% | +$141K | 0.26% | 89 |
|
|
2020
Q3 | $6.96M | Buy |
66,934
+34,394
| +106% | +$3.45M | 0.29% | 71 |
|
|
2020
Q2 | $2.98M | Buy |
32,540
+19,930
| +158% | +$1.91M | 0.16% | 113 |
|
|
2020
Q1 | $1.14M | Sell |
12,610
-676
| -5% | -$71.9K | 0.07% | 186 |
|
|
2019
Q4 | $1.51M | Buy |
13,286
+1,736
| +15% | +$190K | 0.08% | 192 |
|
|
2019
Q3 | $1.25M | Buy |
11,550
+1,566
| +16% | +$163K | 0.07% | 221 |
|
|
2019
Q2 | $972K | Sell |
9,984
-14,456
| -59% | -$1.32M | 0.06% | 234 |
|
|
2019
Q1 | $2.23M | Buy |
24,440
+538
| +2% | +$48.2K | 0.15% | 156 |
|
|
2018
Q4 | $2.17M | Buy |
23,902
+2,301
| +11% | +$215K | 0.15% | 148 |
|
|
2018
Q3 | $2.13M | Buy |
21,601
+119
| +0.6% | +$11K | 0.15% | 154 |
|
|
2018
Q2 | $1.84M | Buy |
21,482
+1,843
| +9% | +$154K | 0.14% | 165 |
|
|
2018
Q1 | $1.57M | Sell |
19,639
-7,423
| -27% | -$612K | 0.12% | 175 |
|
|
2017
Q4 | $2.19M | Sell |
27,062
-4,029
| -13% | -$323K | 0.15% | 147 |
|
|
2017
Q3 | $2.42M | Buy |
31,091
+6,110
| +24% | +$507K | 0.17% | 135 |
|
|
2017
Q2 | $2.22M | Buy |
24,981
+8,200
| +49% | +$691K | 0.19% | 105 |
|
|
2017
Q1 | $1.35M | Buy |
+16,781
| New | +$1.31M | 0.11% | 160 |
|
Other funds holding MDT
VCM
VPM
Cerity Partners's MDT Position: Q2 2026 in Review
Cerity Partners increased its Medtronic (MDT) stake by 4.3% in Q2 2026, buying an estimated $2.65M and bringing the position to 788,907 shares worth $61.7M. The position accounts for 0.07% of the portfolio, ranked #215.
Cerity Partners first reported a position in MDT in Q1 2017 and has held it in 38 quarters since. The position peaked at $76M in Q4 2025. 1,968 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Cerity Partners held 788,907 shares of Medtronic worth $61.7M as of Q2 2026.
- Cerity Partners bought 32,863 Medtronic shares in Q2 2026, an estimated $2.65M.
- Medtronic made up 0.07% of Cerity Partners's portfolio in Q2 2026, its #215 holding.
- Cerity Partners first reported a position in Medtronic in Q1 2017 and has held it in 38 quarters since.
- Cerity Partners's Medtronic position peaked at $76M in Q4 2025.
- 1,968 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.